Recent News

Cancer and Immunotherapy Symposium Hosted by ACEA Biosciences Gathers Clinicians and Scientists From Around the World April 7, 2017Researchers from academia, industry, and federal agencies convened in Washington, D.C. this week to discuss recent progress in diverse areas of basic and applied cancer research. As a forum to promote scientific exchange and collaboration among scientists working at the forefront of cancer related disciplines, ACEA Biosciences hosted its annual Cancer and Immunotherapy symposium March 31-April 1 at the Renaissance ... Read More
Recipients of ACEA Bioscience’s Travel Award Announced for Winter 2017 March 28, 2017ACEA congratulates Dr. Calum Robb and Dr. Rentian Wu for winning the Winter 2017 Research Travel Award. ACEA Biosciences, a privately owned biotechnology company that develops cutting edge instrumentation for cell-based assays, disperses a quarterly travel award to noteworthy scientists who will be presenting research using ACEA Biosciences’ technology at scientific conferences.  Today the company announced that its new round ... Read More
Endocrine Disrupting Chemicals Identified Using xCELLigence® Real-Time Cell Analysis March 20, 2017ACEA Biosciences develops novel assay for the rapid and facile detection of agonists and antagonists of key endocrine receptors. Endocrine-disrupting chemicals (EDCs) are substances that interfere with the ability of endogenous hormones to regulate homeostasis via their cognate nuclear receptors. By either mimicking ligands (agonists) or inhibiting ligand binding activity (antagonists), EDCs produce adverse reproductive, neurological, proliferative, and immunological disorders. ... Read More
ACEA Biosciences Hires Roger Luo as Vice President of Global Clinical Development February 28, 2017San Diego biotech recruits expertise from Johnson & Johnson to help oversee global clinical trials of its lung cancer drug candidate. ACEA Biosciences, a pioneer in cell analysis instrumentation and the development of novel pharmaceuticals for the treatment of chronic diseases, has announced Dr. Roger (Feng) Luo as the new Vice President of Global Clinical Development. With more than 15 ... Read More
TechNews: Biotechniques January 2017 issue features Dr. Xiaobo Wang February 2, 2017Biotechniques January 2017 issue features Dr. Xiaobo Wang, Chief Technology Officer at ACEA Biosciences, in the Tech News article – Big Labs and Tiny Instruments. Dr. Wang who helped develop the high performance NovoCyte benchtop flow cytometer, discussed that the adoption of smaller footprint flow cytometer has been robust and that researchers now have the opportunity to reap the benefits ... Read More
View all News

  Upcoming Events

AAI | May 12-16, 2017 | Washington, D.C.Join us at AAI in Washington, D.C. at booth #801. This is one of the largest annual gathering of immunologists worldwide. At IMMUNOLOGY 2017™, you’ll hear from global leaders in immunology and talented early-career investigators alike—all discussing breakthroughs across the full spectrum of topics in the field. Join us for lunch while learning about the capabilities of the NovoCyte flow cytometer in ... Read More
PEGS | May 1-4, 2017 | Washington, D.C.Join us at PEGS in Boston at booth #141. At this conference, network with world-class experts from pharma, academia, and government to share information, case studies, and best practices covering a vast area of biologic drug development and hear in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analysis, immunogenicity, and therapeutics.Read More
Experimental Biology 2017 | April 22-25, 2017 | Chicago, ILJoin ACEA Biosciences at EB from April 22-25 in Chicago, IL. This event focus areas include anatomy, biochemistry and molecular biology, investigative pathology, nutrition, pharmacology, and physiology. Come check out our booth #708.Read More
View all Events

  ACEA Newsletter

Sign up for the ACEA Newsletter.

View ACEA Newsletters